Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-05-26 AGM Information
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Protokoll fra ordinær generalforsamling - Attachment: 20250526_ABS_Minutes_from_Ordinary_General_Meeting.pdf
AGM Information Classification · 99% confidence The document is explicitly titled "PROTOKOLL FRA GENERALFORSAMLING I ARCTIC BIOSCIENCE AS" (MINUTES FROM ORDINARY GENERAL MEETING IN ARCTIC BIOSCIENCE AS). It details the proceedings, resolutions passed (including approval of annual accounts, remuneration, and election of board members), and the final voting results from a meeting held on May 26, 2025. This content directly corresponds to the documentation generated following an Annual General Meeting (AGM). While it contains voting results (DVA) and discusses the annual report (10-K), the primary document type capturing the entire meeting record and its outcomes is the AGM Protocol/Minutes. Therefore, the classification is AGM-R.
2025-05-26 Norwegian
Arctic Bioscience - Minutes of the Annual General Meeting
AGM Information Classification · 98% confidence The document explicitly states it contains the "Minutes of the Annual General Meeting" of Arctic Bioscience AS, held on May 26, 2025. It details that all agenda items were approved, including changes to the Board of Directors. This content directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (1810 chars) is short, but since it contains the actual minutes/summary of the meeting rather than just announcing that the minutes are available, AGM-R is more specific than RPA or RNS.
2025-05-26 English
Arctic Bioscience - Protokoll fra ordinær generalforsamling
AGM Information Classification · 98% confidence The document title is "Arctic Bioscience - Protokoll fra ordinær generalforsamling" (Minutes from the Annual General Meeting). The text explicitly states that the Annual General Meeting (AGM) was held on May 26, 2025, and that the protocol (minutes) is attached. Although it contains AGM details (like board changes), the document itself is presented as the official minutes/protocol of the meeting, which falls under the scope of AGM materials. Given the options, AGM-R (AGM Information) is the most appropriate classification for the minutes of an Annual General Meeting.
2025-05-26 Norwegian
Arctic Bioscience - Q1 2025 Operational update - Growth-platform established
Interim / Quarterly Report Classification · 95% confidence The document is an 'Operational update' for Q1 2025, which includes key financial highlights, revenue figures, gross profit, EBITDA, and liquidity data. It provides a comprehensive overview of the company's performance for the quarter, fitting the definition of an Interim/Quarterly Report (IR) as it contains substantive financial data and analysis rather than just being a brief announcement. Q1 2025
2025-05-15 English
Arctic Bioscience - 1. kvartal 2025 operasjonell oppdatering - Vekstplattform etablert
Earnings Release Classification · 100% confidence The document provides a detailed operational update for the first quarter (1. kvartal) of 2025, including key financial metrics (Sales revenue, Adjusted EBITDA, Liquidity) compared to the previous year (1. kvartal 2024). It discusses clinical trial progress (HeROPA study), financing activities, and outlook for the supplement business. This structure—a comprehensive review of a specific, shorter reporting period with key figures and management commentary—is characteristic of an Interim/Quarterly Report (IR). It is too detailed to be a simple Earnings Release (ER) and is not the full annual filing (10-K). The document length (7049 chars) confirms it is a substantive report, not just a publication announcement (RPA). Q1 2025
2025-05-15 Norwegian
Arctic Bioscience - Registrert aksjekapitalforhøyelse
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement titled "Arctic Bioscience - Registrert aksjekapitalforhøyelse" (Registered Share Capital Increase). It explicitly states that the increase in share capital has been registered in the Register of Business Enterprises and details the new capital amount and number of shares. This directly relates to a change in the company's capital structure due to the exercise of debt conversion rights. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. Although it is a registration notice, the core subject is the capital change itself, making CAP more specific than a general RPA or RNS. The document length is short (1561 chars), but the content is the substance of the capital change, not just an announcement that a report is attached.
2025-05-12 Norwegian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.